Inducing All Our ‘Low-Risk’ Transplant Candidates: Shall We Or Shall We Not?
Journal Title: Journal of Urology & Nephrology - Year 2017, Vol 4, Issue 1
Abstract
Acute rejection episode (ARE) in an allograft recipient has a negative impact on graft survival, and therefore, preventing ARE is of paramount importance. Induction by antibody preparations is one such strategy that has been proven effective in preventing AREs, but there are certain ambiguities in their use particularly in low immunological risk transplants. Anti-interleukin-2 receptor therapy had gained widespread usage in this group of patients because it does not incur additional risks of infectious and malignant sequelae associated with thymoglobulin. However, recent literature found it to be no better than “no induction” strategy. Thymoglobulin, being frequently used in North America for induction even in low risk group, has been used in variable doses across transplant centers. The minimal possible dose of Thymoglobulin that avoids majority of adverse effects while retaining an optimal treatment benefit has not been clearly defined. Moreover, the effects of induction by antibody preparations on long term graft function and survival remain variable. Majority of the published work on induction immunosuppression is retrospective and is difficult to interpret because of a wide spectrum of maintenance immunosuppressive regimen in vogue. This review of literature has been performed to analyse published literature to assess the efficacy and appropriateness of induction agents in “low risk” transplants. We suggest that ‘low-risk patients receiving triple-drug immunosuppression(calcineurin inhibitors, an anti-proliferative agent and steroids) do not need ‘routine’ induction by antibody preparations.
Authors and Affiliations
Ahmed Halawa
Keywords
Related Articles
- EP ID EP207455
- DOI 10.13188/2380-0585
- Views 135
- Downloads 0
Obstructive Uropathy Secondary to Posterior Urethral Valves: Retarding the Progression to End-Stage Kidney Disease in Children
Posterior urethral valve (PUV) is the most common cause of obstructive uropathy leading to chronic kidney disease (CKD) in male newborn infants. The few children that survive have poor prognosis, with over 50% progressin...
Early Surgical Correction of Ureteropelvic Junction Obstruction
Based on the analysis of 131 (from month 1 to 3 years old) children with Ureteropelvic Junction (UPJ) obstruction, who underwent early pyeloplasty, it was found that the incidence of intra and postoperative complications...
A Female Urethral Melanoma Treated with a Bladder Sparing Approach
Malignant melanoma rarely involves the genitourinary organs, however urethral involvement accounts for the majority of documented cases. In comparison to cutaneous melanoma, urethral melanoma is associated with a poor pr...
Handgrip Strength and Weight Predict Long-Term Mortality in Acute Kidney Injury Patients
Introduction: Surviving acute kidney (AKI) patients have a higher late mortality. The negative impact of malnutrition on the early outcome of AKI patients has recently been confirmed by various studies. However, its impa...
Pelvic and Abdominal Lipomatosis – A Rare Case Report with Atypical Presentations
Pelvic lipomatosis is defined as a condition characterized by the diffuse proliferation of normal mature fatty tissue in the perirectal and perivesical region. We present a rare case of 50 years male, normotensive, normo...